CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
80 hedge funds and large institutions have $227M invested in Concert Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 70 → 80 (+10)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
80
Holding in Top 10
1
Calls
$1.12M
Puts
$105K
Top Buyers
| 1 | +$6.72M | |
| 2 | +$4.51M | |
| 3 | +$3.84M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.55M |
| 5 |
BlackRock
New York
|
+$2.62M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$1.91M | |
| 3 | -$1.43M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.03M |
| 5 |
Walleye Capital
New York
|
-$840K |